Non-islet cell hypoglycemia

Annales d'Endocrinologie

Volumn 65, Issue 1, 2004, Pages 99-103

  LeRoith, D ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Hypoglycemia; IGF 2; Non islet cell tumor

Indexed keywords

C PEPTIDE; CORTICOSTEROID; GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SULFONYLUREA DERIVATIVE;

ADRENAL INSUFFICIENCY; BINDING AFFINITY; CONFERENCE PAPER; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; ENDOCRINE DISEASE; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOGLYCEMIA; HYPOPITUITARISM; INSULIN BLOOD LEVEL; INSULINOMA; NON ISLET CELL TUMOR; POSITRON EMISSION TOMOGRAPHY; SYNDROME DELINEATION; TUMOR DIAGNOSIS;

EID: 2342618281     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(04)95641-7     Document Type: Conference Paper

References (24)

1. Baxter RC and Daughaday WH. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J Clin Endocrinol Metab 1991; 73: 696-702.
2. Christofori G, Naik P and Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 1994; 369: 414-8.
3. Christofori G, Naik P and Hanahan D. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis. Nat Genet 1995; 10: 196-201.
4. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M and Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 1988; 319: 1434-40.
5. Daughaday WH and Trivedi B. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 75: 110-5, 1992.
6. Eastman RC, Carson RE, Orloff DG, Cochran CS, Perdue JF, Rechler MM, Lanau F, Roberts CT, Jr., Shapiro J, Roth J and et al. Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. J Clin Invest 89: 1958-63, 1992.
7. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A and Vigneri R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19: 3278-88, 1999.
8. Frittitta L, Sciacca L, Catalfamo R, Ippolito A, Gangemi P, Pezzino V, Filetti S and Vigneri R. Functional insulin receptors are overexpressed in thyroid tumors: is this an early event in thyroid tumorigenesis? Cancer 85: 492-8, 1999.
9. Frystyk J, Skjaerbaek C, Zapf J and Orskov H. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia. Diabetologia 41: 589-94, 1998.
10. Giddings SJ and Carnaghi LR. Insulin receptor gene expression during development: developmental regulation of insulin receptor mRNA abundance in embryonic rat liver and yolk sac, developmental regulation of insulin receptor gene splicing, and comparison to abundance of insulin-like growth factor 1 receptor mRNA. Mol Endocrinol 6: 1665-72, 1992.
11. Kalli KR, Falowo 01, Bale LK, Zschunke MA, Roche PC and Conover CA. Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling. Endocrinology 143: 3259-67, 2002.
12. Kosaki A and Webster NJ. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J Biol Chem 268: 21990-6, 1993.
13. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 336: 633-40, 1997.
14. Lowe WL, Jr., Roberts CT, Jr., LeRoith D, Rojeski MT, Merimee TJ, Fui ST, Keen H, Arnold D, Mersey J, Gluzman S and et al. Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid. J Clin Endocrinol Metab 69: 1153-9, 1989.
15. Moller DE, Yokota A, Caro JF and Flier JS. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3: 1263-9, 1989.
16. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R and Belfiore A. Insulin and insulin-like growth factor-I (IGF-I) receptors have different biological characteristics depending on the insulin receptor isoform involved. J. Biol. Chem. 277: 39684-96, 2002.
17. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID and Vigneri R. Elevated insulin receptor content in human breast cancer. J Clin Invest 86: 1503-10, 1990.
18. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K and Hintz R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 269: 13779-84, 1994.
19. Sciacca L, Mineo R, Pandini G, Murabito A, Vigneri R and Belfiore A. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A. Oncogene 21: 8240-50, 2002.
20. Yang Y, Hu JF, Ulaner GA, Li T, Yao X, Vu TH and Hoffman AR. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites. J Cell Biochem 90: 1038-55, 2003.
21. Yao X, Hu JF, Daniels M, Shiran H, Zhou X, Y an H, Lu H, Zeng Z, Wang Q, Li T and Hoffman AR. A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J Clin Invest 111: 265-73, 2003.
22. Zapf J. Role of insulin-like growth factor (IGF) II and IGF binding proteins in extrapancreatic tumour hypoglycaemia. J Intern Med 234: 543-52, 1993.
23. Zapf J. Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia. Horm Res 42: 20-6, 1994.
24. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B and Kinzler KW. Gene expression profiles in normal and cancer cells. Science 276: 1268-72, 1997.